CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets

Area of Science:

• Immunology
• Cell Biology
• Human NK Cell Differentiation

Background:

• Human natural killer (NK) cells exist as distinct subsets: CD56(bright) NK cells with high interferon-gamma (IFN-gamma) and low cytotoxicity, and CD56(dim) NK cells with low IFN-gamma and high cytotoxicity.
• Killer immunoglobulin-like receptors (KIRs) are expressed at low/no levels on CD56(bright) NK cells and highly on CD56(dim) NK cells.
• The developmental relationship and intermediate stages between these NK cell subsets remain incompletely understood.

Purpose of the Study:

• To investigate the hypothesis that human NK cell maturation progresses through intermediate stages.
• To utilize CD94 surface expression as a marker to identify potential intermediary NK cell populations.
• To characterize the functional and phenotypic properties of CD94-expressing CD56(dim) NK cells in relation to known subsets.

Main Methods:

• Flow cytometry was used to analyze NK cell subsets based on CD56 and CD94 expression.
• Expression levels of CD62L, CD2, and KIR were quantified on different NK cell populations.
• Interferon-gamma (IFN-gamma) production, STAT4 phosphorylation, granzyme B, and perforin expression were assessed.
• CD94-mediated redirected killing assays were performed to evaluate cytotoxic potential.

Main Results:

• A distinct subset, CD94(high)CD56(dim) NK cells, was identified with intermediate expression of CD62L, CD2, and KIR compared to CD56(bright) and CD94(low)CD56(dim) NK cells.
• CD94(high)CD56(dim) NK cells exhibited intermediate IFN-gamma production, influenced by differential interleukin-12-mediated STAT4 phosphorylation.
• This intermediate subset showed higher granzyme B and perforin expression and CD94-mediated killing capacity than CD56(bright) NK cells, but lower than CD94(low)CD56(dim) NK cells.

Conclusions:

• CD94 surface expression density on CD56(dim) NK cells serves as a marker for a functional and developmental intermediary stage.
• These findings support a model of human NK cell differentiation where CD56(bright) NK cells mature progressively towards a CD56(dim) phenotype.
• The study elucidates a continuum of NK cell differentiation, with CD94(high)CD56(dim) cells representing a crucial transitional population.